U46619

U46619
Nazivi
	IUPAC naziv (Z)-7-[(1S,4R,5R,6S)-5-[(E,3S)-3-hidroksiokt-1-enil]-3-oksabiciklo[2.2.1]heptan-6-il]hept-5-enoinska kiselina
Identifikacija
CAS broj	56985-40-1;
3D model (Jmol)	interaktivna slika;
ECHA InfoCard	100.164.944
IUPHAR/BPS	1888;
PubChem C ID	5311493;
	SMILES CCCCC[C@H](O)/C=C/[C@H]1[C@@H]2OC[C@@H](C2)[C@@H]1C/C=C\CCCC(O)=O; ; ; ; ; ;
Svojstva
Hemijska formula	C21H34O4
Molarna masa	350,49 g/mol
	Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa).
	verifikuj (šta je ?)
	Reference infokutije

U46619 je stabilni sintetički analog prostaglandina PGH₂ koji je prvi put pripremnljen 1975.^[3] U46619 je vazokonstriktor koji oponaša hidroosmotičko dejstvo vazopresina.^[4] On takođe oponaša dejstvo tromboksana putem aktivacije fosfolipaze C.^[5]^[6]

Reference[uredi | uredi izvor]

^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003. уреди
^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
^ Bundy, G. L. (1975). „Synthesis of prostaglandin endoperoxide analogs”. Tetrahedron Letters. 24 (24): 1957—1960. doi:10.1016/S0040-4039(00)72333-1.
^ Burch, Ronald M.; Halushka, Perry V. (1983). „Calcium-45 fluxes in isolated toad bladder epithelial cells: effects of agents which alter water or sodium transport”. Journal of Pharmacology and Experimental Therapeutics. 224 (1): 108—17. PMID 6294273.
^ Rittenhouse, Susan E. (1984). „Activation of human platelet phospholipase C by ionophore A23187 is totally dependent upon cyclo-oxygenase products and ADP”. Biochemical Journal. 222 (1): 103—110. PMC 1144149 . PMID 6433894.
^ Michael P. Walsh; et all (2005). „Thromboxane A2-induced contraction of rat caudal arterial smooth muscle involves activation of Ca2+ entry and Ca2+sensitization: Rho-associated kinase-mediated phosphorylation of MYPT1 at Thr-855 but not Thr-697” (PDF). Biochem. J. 389 (Pt 3): 763—74. PMC 1180727 . PMID 15823093. doi:10.1042/BJ20050237. Архивирано из оригинала (PDF) 13. 07. 2011. г. Приступљено 27. 10. 2012.

Spoljašnje veze[uredi | uredi izvor]

[1] Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003. уреди

[2] Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.

[3] Bundy, G. L. (1975). „Synthesis of prostaglandin endoperoxide analogs”. Tetrahedron Letters. 24 (24): 1957—1960. doi:10.1016/S0040-4039(00)72333-1.

[4] Burch, Ronald M.; Halushka, Perry V. (1983). „Calcium-45 fluxes in isolated toad bladder epithelial cells: effects of agents which alter water or sodium transport”. Journal of Pharmacology and Experimental Therapeutics. 224 (1): 108—17. PMID 6294273.

[5] Rittenhouse, Susan E. (1984). „Activation of human platelet phospholipase C by ionophore A23187 is totally dependent upon cyclo-oxygenase products and ADP”. Biochemical Journal. 222 (1): 103—110. PMC 1144149 . PMID 6433894.

[6] Michael P. Walsh; et all (2005). „Thromboxane A2-induced contraction of rat caudal arterial smooth muscle involves activation of Ca2+ entry and Ca2+sensitization: Rho-associated kinase-mediated phosphorylation of MYPT1 at Thr-855 but not Thr-697” (PDF). Biochem. J. 389 (Pt 3): 763—74. PMC 1180727 . PMID 15823093. doi:10.1042/BJ20050237. Архивирано из оригинала (PDF) 13. 07. 2011. г. Приступљено 27. 10. 2012.

[1]

[2]

[3]

[4]

[5]

[6]